CIK cell cytotoxicity is a predictive biomarker for CIK cell immunotherapy in postoperative patients with hepatocellular carcinoma

Pan, QZ; Liu, Q; Zhou, YQ; Zhao, JJ; Wang, QJ; Li, YQ; Tang, Y; Gu, JM; He, J; Chen, SP; Weng, DS; Xia, JC

Weng, DS; Xia, JC (corresponding author), Sun Yat Sen Univ, Ctr Canc, Collaborat Innovat Ctr Canc Med, State Key Lab Oncol South China, Guangzhou, Peoples R China.; Weng, DS; Xia, JC (corresponding author), Sun Yat Sen Univ, Ctr Canc, Dept Biotherapy, Guangzhou 510060, Peoples R China.

CANCER IMMUNOLOGY IMMUNOTHERAPY, 2020; 69 (5): 825

Abstract

Adjuvant cytokine-induced killer (CIK) cell immunotherapy has shown potential in improving the prognosis of hepatocellular carcinoma (HCC) patients af......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索